C12N 2710/16123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2710/16123 (Virus like particles [vlp]) appears on 4 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 14
- Assignees
- 9
- Inventors
- 21
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Vaccine composition7 Oct 2025US 12,433,944 B2SpyBiotech Limited
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response7 Feb 2023US 11,572,389 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Recombinant virus-like particles encoded by multi-gene vector12 Apr 2016US 9,309,536 B2Pfizer Inc.
- Alpha virus-based cytomegalovirus vaccines2 Sep 2008US 7,419,674 B2Alpha Vax, Inc.
- Veterinary compositions of modified virus-like particles of cmv and ngf antigens12 Mar 2026US 2026/0069668 A1
- Modified virus-like particles of cmv26 Feb 2026US 2026/0055428 A1Saiba Animal Health AG
- Virus-like vesicles (vlvs) based vaccines and methods of preventing, ameliorating, and/or treating covid-19 and/or hepatocellular carcinoma (hcc)5 Feb 2026US 2026/0034208 A1Yale University
- Vaccine composition8 Jan 2026US 2026/0007740 A1SpyBiotech Limited
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response15 Aug 2024US 2024/0270796 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Most cited
By later US patents